The Cannabis Observer

Finance General Global Hemp Legal Marketing Medical Partner content Join

Finance General Global Hemp Legal Marketing Medical Partner content Join

ThirdGate Capital

Zelira Therapeutics shares surge more than 120% on back of US$33m SPV investment

Finance

Zelira Therapeutics shares surge more than 120% on back of US$33m SPV investment

January 19, 2026

Subscribe to The Cannabis Observer newsletter before you leave

Before you go

Get the briefing before you leave

One email a week of cannabis industry coverage. Free. No spam.

Weekly roundup of regulation, access schemes, and market moves
Filtered for industry professionals
Unsubscribe in one click

Email address

Join 87 cannabis industry readers already subscribed

Get the free weekly cannabis industry briefing.

Email address

© 2026 The Cannabis Observer · Privacy Policy · Terms & Conditions